Keyhaven Capital Partners backs Miura Partners’ investment into Proclinic Group
- Keyhaven takes co-lead role, backing Miura’s single asset GP-led investment into the pan-European dental distribution platform
- The transaction saw Miura Partners roll Proclinic into a new structure to undertake the next phase of growth
- This includes consolidation through strategic acquisitions across Europe to further bolster Proclinic’s standing in the industry
Keyhaven Capital Partners (“Keyhaven”), the specialist private equity firm dedicated to the European lower mid-market, co-leads the single asset GP-led investment in Proclinic Group (“Proclinic”) via a more than €200 million transaction managed by Miura Partners (“Miura”). The transaction is backed by the founding Raneda family, Manuel Alfonso (Group CEO) and has drawn support from several other institutional investors.
Founded in 1983 and headquartered in Zaragoza in Spain, Proclinic is a leading pan-European integrated provider of solutions for the dental sector. The company offers a broad product portfolio of dental consumables and equipment, as well as value-added services including after-sales training and technical support, providing a one-stop solution across the value chain to its clients. The company has a strong omnichannel presence in key European markets, with more than 150,000 product SKUs and over 42,000 active customers.
The renewed partnership with Proclinic will further develop its growth plan based on the reinforcement of the commercial strategy, the expansion of products and services, the integration of the latest acquisitions and through pursuing new M&A opportunities in other European countries.
Commenting on the announcement, Teddy Mouawad, Partner at Keyhaven Capital Partners said: “We are delighted to continue our longstanding relationship with Miura. Proclinic embodies the qualities we look for in a business: a market-leading position in a defensive sector with favourable trends, an innovative platform with above-market growth and margins, and a proven track record of organic expansion and M&A. We look forward to supporting Miura and the management team with further internationalisation to establish Proclinic as a European industry leader.”
Carlos Julià, Managing Partner at Miura Partners said: “We are very excited about strengthening our partnership with Proclinic and backing the Raneda family and the management team in the next phase. The dental sector has solid market fundamentals given the raising patient demands, the ageing of the population and technological improvements. Proclinic is a well-invested and differentiated platform with a proven ability to execute growth and we will continue to consolidate the market through strategic acquisitions. We would also like to thank the trust of our investors who have committed their capital.”
About Keyhaven Capital
Keyhaven is a specialist private equity firm investing in lower mid-market businesses across Europe. With a diverse team, a network embedded in local markets and a flexible approach to deal making, Keyhaven works with niche industry leaders to accelerate growth, building robust, sustainable businesses that deliver for their investors, employees and local communities. Since its foundation in 2003, Keyhaven has invested or advised on investments worth in excess of €2.2 billion, representing over 65 transactions across Europe.
About Miura Partners Miura Partners is a purpose-driven private equity firm. With offices in Barcelona and Madrid, the firm specializes in investing in small and medium-sized family-owned and entrepreneurial companies. Miura provides attractive growth and innovation plans with a clear focus on sustainability, under its three investment strategies: buy-outs, impact, and agribusiness. Since 2008, Miura has invested in more than 70 companies, for a total value in excess of €3.0 billion. Currently, the firm has €1.5 billion assets under Management.
For all media enquiries, please contact:
Instinctif Partners
keyhaven@instinctif.com
+44 207 457 2020